Breaking News
14 hours ago
Simantini Singh Deo

Sanofi's Sarclisa SC becomes the EU's first anticancer therapy approved via on-body injector, setting a new precedent for drug-device combination manufacturing.
Simantini Singh Deo

Intravacc formalises integrated analytical development services targeting CMC de-risking and IND acceleration for vaccine and biologics developers.
Simantini Singh Deo

Novartis presents remibrutinib Phase III and extension data across three immune-mediated indications at EAACI 2026, with CMC and regulatory implications.
Simantini Singh Deo

Cormica names Caroline Aiken Technical Director to integrate analytical, regulatory, and testing capabilities across its global CRO network.
Simantini Singh Deo
